Modulating the blood–brain tumor barrier for improving drug delivery efficiency and efficacy

Abstract

The blood–brain barrier (BBB) is a highly regulated and efficient barrier that controls the mass transfer between blood and brain, severely limits brain penetration of systemically administered therapeutics. During the onset and progression of brain tumors, BBB alters, and the blood–brain tumor barrier (BBTB) forms. Though BBTB differs from BBB in certain aspects, such as neuronal connections and aberrant pericyte distribution, it retains critical aspects of BBB. Hence, one major challenge in the development of therapeutics for brain tumor is to achieve sufficient BBTB penetration thus improving the efficiency of drug delivery to the tumor site. In this review, we summarize the strategies that can overcome BBTB and improve BBTB penetration efficiency from the perspectives of regulating BBTB structure and transport processes.

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments

“…The restrictive nature of the BBB is a physical barrier to drug delivery to the brain. When designing a drug for the brain, the possibility of the BBB blocking the molecule must be considered creating methods that bypass the BBB obstacle 31,40 . The integrity of the BBB is influenced by numerous factors, among these the state of health and the age of the subject.…”

A state-of-the-art liposome technology for glioblastoma treatment

“…Alternatively, liposomes can easily cross the BBB and enhance the drug accumulation in the targeted site of the brain tumors. 21,26,108,109 Compared to other drug delivery systems for the BBB, liposomes have significant potential. In addition, the surface modification, structure, and composition of liposomes can increase the bioavailability, reduce peripheral toxicity, and increase the stability of drugs.…”

Fruit‐Derived Extracellular‐Vesicle‐Engineered Structural Droplet Drugs for Enhanced Glioblastoma Chemotherapy

“…[1,2] Utilizing solid nanoparticles as vehicles to deliver chemotherapeutics has been considered as one of the most promising strategies to overcome the limitation of BBB/BBTB. [3][4][5][6][7][8] Meanwhile, these nanoparticles are usually modified with specific biomolecules to further improve their capacities in crossing the The fruitderived ESDDs were fabricated by programming the self-assembly of fruit-derived EVs at the DOX@squalene-PBS interface. B) Schematic illustration of interfacial interaction between ESDDs and neovascular endothelial cells or glioblastoma cells.…”